JP2007511210A5 - - Google Patents

Download PDF

Info

Publication number
JP2007511210A5
JP2007511210A5 JP2006538375A JP2006538375A JP2007511210A5 JP 2007511210 A5 JP2007511210 A5 JP 2007511210A5 JP 2006538375 A JP2006538375 A JP 2006538375A JP 2006538375 A JP2006538375 A JP 2006538375A JP 2007511210 A5 JP2007511210 A5 JP 2007511210A5
Authority
JP
Japan
Prior art keywords
seq
oligonucleotide
nrp
sequence
use according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2006538375A
Other languages
English (en)
Japanese (ja)
Other versions
JP5026083B2 (ja
JP2007511210A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2004/036203 external-priority patent/WO2005042561A2/en
Publication of JP2007511210A publication Critical patent/JP2007511210A/ja
Publication of JP2007511210A5 publication Critical patent/JP2007511210A5/ja
Application granted granted Critical
Publication of JP5026083B2 publication Critical patent/JP5026083B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2006538375A 2003-10-31 2004-11-01 神経再生ペプチド及び脳損傷治療におけるそれらの使用方法 Expired - Fee Related JP5026083B2 (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US51601803P 2003-10-31 2003-10-31
US60/516,018 2003-10-31
US58504104P 2004-07-02 2004-07-02
US60/585,041 2004-07-02
US61627104P 2004-10-05 2004-10-05
US60/616,271 2004-10-05
PCT/US2004/036203 WO2005042561A2 (en) 2003-10-31 2004-11-01 Neural regeneration peptides and methods of use

Publications (3)

Publication Number Publication Date
JP2007511210A JP2007511210A (ja) 2007-05-10
JP2007511210A5 true JP2007511210A5 (https=) 2007-08-23
JP5026083B2 JP5026083B2 (ja) 2012-09-12

Family

ID=34557374

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006538375A Expired - Fee Related JP5026083B2 (ja) 2003-10-31 2004-11-01 神経再生ペプチド及び脳損傷治療におけるそれらの使用方法

Country Status (3)

Country Link
EP (1) EP1685151A4 (https=)
JP (1) JP5026083B2 (https=)
WO (1) WO2005042561A2 (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4988711B2 (ja) * 2005-05-06 2012-08-01 クロンズ ホールディングズ カンパニー リミテッド 神経再生ペプチド及びそれを含む処方物
WO2007011595A2 (en) * 2005-07-15 2007-01-25 Neuren Pharmaceuticals Limited Neural regeneration peptides and antioxidants protect neurons from degeneration
BRPI0617823A2 (pt) * 2005-10-31 2011-08-09 Laboratoires Serono Sa uso de sdf-1 para o tratamento e/ou prevenção de doenças neurológicas e composição farmacêutica
WO2009051844A1 (en) 2007-10-17 2009-04-23 Neuren Pharmaceuticals Limited Synthetic analogues of neural regeneration peptides
WO2013112002A1 (ko) * 2012-01-27 2013-08-01 의료법인 성광의료재단 뇌 손상 증세의 경감 또는 완화에 대한 바이오마커
US20160015771A1 (en) * 2012-07-27 2016-01-21 Curonz Holdings Company Limited Method of treating optic nerve damage, ophthalmic ischemia or ophthalmic reperfusion injury
JP2016514954A (ja) * 2013-03-08 2016-05-26 クロンズ ホールディングズ カンパニー リミテッドCuronz Holdings Company Limited 神経再生ペプチドおよびその使用
AU2014332346B2 (en) * 2013-10-11 2019-01-24 Tarix Pharmaceuticals Ltd. Novel peptide compositions

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995006662A1 (en) * 1993-09-01 1995-03-09 Start Technology Partnership Neuron regulatory factor for promoting neuron survival
EP1572887A4 (en) * 2001-08-24 2008-12-24 Neuren Pharmaceuticals Ltd NERVE REGENERATING PEPTIDE AND METHOD FOR THEIR USE IN THE TREATMENT OF A BRAIN DAMAGE

Similar Documents

Publication Publication Date Title
Gong et al. Spatiotemporal dynamics of the molecular expression pattern and intercellular interactions in the glial scar response to spinal cord injury
Lindvall et al. Stem cells in human neurodegenerative disorders—time for clinical translation?
Begni et al. Cellular and molecular mechanisms of the brain-derived neurotrophic factor in physiological and pathological conditions
Siegenthaler et al. We have got you ‘covered’: how the meninges control brain development
Horner et al. Regenerating the damaged central nervous system
Zhou et al. Pentraxin 3 contributes to neurogenesis after traumatic brain injury in mice
US20110306557A1 (en) Neural regeneration peptides and methods for their use in treatment of brain damage
Lee et al. Overexpression of Bcl‐XL in human neural stem cells promotes graft survival and functional recovery following transplantation in spinal cord injury
Wang et al. Phenotypical analysis of adult rat olfactory ensheathing cells on 3-D collagen scaffolds
Takano et al. Brain-derived neurotrophic factor enhances neurite regeneration from retinal ganglion cells in aged human retina in vitro
Yuan et al. From physiology to pathology of astrocytes: highlighting their potential as therapeutic targets for CNS injury
Nesti et al. Human dental pulp stem cells protect mouse dopaminergic neurons against MPP+ or rotenone
Wang et al. Adipose Stem Cell‐Based Clinical Strategy for Neural Regeneration: A Review of Current Opinion
JP4943847B2 (ja) 抗分泌性因子の新規の使用
Wen et al. Effects of primary microglia and astrocytes on neural stem cells in in vitro and in vivo models of ischemic stroke
Shahriary et al. Neuregulin‐1 Fosters Supportive Interactions between Microglia and Neural Stem/Progenitor Cells
JP2007511210A5 (https=)
Hamidabadi et al. Promoting motor functions in a spinal cord injury model of rats using transplantation of differentiated human olfactory stem cells: A step towards future therapy
JP2008521796A5 (https=)
WO2004060910A3 (en) Bioactive peptides and unique ires elements from myelin proteolipid protein plp/dm20
Gu et al. Expression and regulation of versican in neural precursor cells and their lineages
JP5026083B2 (ja) 神経再生ペプチド及び脳損傷治療におけるそれらの使用方法
US20240277902A1 (en) Method for manufacturing peripheral nerve-mimicking microtissue and uses thereof
TWI575069B (zh) A method for continuously maintaining the growth of motor neuron precursor cells and a pharmaceutical composition
El Tal et al. Neural‐Tissue Engineering Interventions for Traumatic Brain Injury